Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Fosun Pharmaceutical Group Co., Ltd.    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL GROUP CO.,

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 109 70657 94865 08685 253--
Entreprise Value (EV)1 122 75072 60477 05098 802100 743102 559
P/E ratio 35,0x21,7x20,5x25,6x21,7x18,1x
Yield 0,85%1,38%1,47%1,15%1,39%1,64%
Capitalization / Revenue 5,92x2,34x2,28x2,63x2,21x1,99x
EV / Revenue 6,62x2,94x2,70x3,05x2,62x2,39x
EV / EBITDA 24,4x21,1x13,1x22,8x18,3x16,6x
Price to Book 4,38x2,13x2,14x2,67x2,44x2,14x
Nbr of stocks (in thousands) 2 495 0612 563 0612 562 8992 562 899--
Reference price (CNY) 44,523,326,635,535,535,5
Last update 03/26/201803/25/201903/30/202006/17/202006/17/202006/10/2020
1 CNY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 18 53424 71428 58532 40838 51542 944
EBITDA1 5 0213 4375 8744 3355 4966 190
Operating profit (EBIT)1 4 0752 0914 4942 7723 6103 876
Operating Margin 22,0%8,46%15,7%8,55%9,37%9,03%
Pre-Tax Profit (EBT)1 4 0623 5804 5264 7435 8186 750
Net income1 3 1242 7083 3223 2644 1264 983
Net margin 16,9%11,0%11,6%10,1%10,7%11,6%
EPS2 1,271,071,301,391,641,96
Dividend per Share2 0,380,320,390,410,490,58
Last update 03/26/201803/25/201903/30/202006/30/202006/30/202006/10/2020
1 CNY in Million
2 CNY
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 13 04414 65711 96413 54915 49017 307
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,60x4,26x2,04x3,13x2,82x2,80x
Free Cash Flow1 510-367-7063 5543 0332 945
ROE (Net Profit / Equities) 13,0%10,2%11,6%9,66%11,6%11,9%
Shareholders' equity1 23 99826 59528 75933 80335 54541 769
ROA (Net Profit / Asset) 5,91%4,09%4,53%3,30%4,83%3,43%
Assets1 52 86866 25773 34198 90385 485145 147
Book Value Per Share2 10,210,912,413,314,616,6
Cash Flow per Share2 1,031,151,261,761,661,95
Capex1 2 0703 3173 9282 9163 0123 161
Capex / Sales 11,2%13,4%13,7%9,00%7,82%7,36%
Last update 03/26/201803/25/201903/30/202006/30/202006/30/202006/10/2020
1 CNY in Million
2 CNY
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (CNY)
85 252 881 383
Capitalization (USD)
12 178 287 153
Net sales (CNY)
28 585 152 030
Net sales (USD)
4 085 046 906
Number of employees
31 370
Sales / Employee (CNY)
911 226
Sales / Employee (USD)
130 221
Free-Float
62,3%
Free-Float capitalization (CNY)
53 122 408 331
Free-Float capitalization (USD)
7 588 481 848
Avg. Exchange 20 sessions (CNY)
1 669 063 705
Avg. Exchange 20 sessions (USD)
238 522 556
Average Daily Capital Traded
2,0%
EPS & Dividend